Skip to main content
Fig. 3 | Critical Care

Fig. 3

From: Antimicrobials for the treatment of drug-resistant Acinetobacter baumannii pneumonia in critically ill patients: a systemic review and Bayesian network meta-analysis

Fig. 3

Surface under the cumulative ranking curve (SUCRA) rankings and posterior estimates of treatment effect on all-cause mortality. Greater SUCRA value indicate higher probability of being the best treatment for reducing all-cause mortality. Abbreviations: CAR carbapenem (imipenem or meropenem), COL colistin, CrI credible interval, FOS fosfomycin, GLY glycopeptide (vancomycin or teicoplanin), HD high-dose, IH inhaled, IV intravenous, RIF rifampin, SUL sulbactam, TIG tigecycline

Back to article page

Critical Care

ISSN: 1364-8535